Glenn Schulman

Glenn Schulman

Keine laufenden Positionen mehr
Health Technology
Consumer Services

Profil

Glenn Schulman, formerly the Director of Investor Relations at CuraGen Corp., Investor Relations Contact at Achillion Pharmaceuticals, Inc., Senior VP of Communications & Investor Relations at Aurinia Pharmaceuticals, Inc., VP of Investor Relations & Corporate Communications at X4 Pharmaceuticals, Inc., Senior Vice President of Investor Relations at ProKidney Corp., and VP and Head of Investor Relations & Communications at IN8bio, Inc., has a graduate degree from Yale University, an undergraduate degree from Philadelphia College of Pharmacy, and a doctorate from Ernest Mario School of Pharmacy.

Ehemalige bekannte Positionen von Glenn Schulman

UnternehmenPositionEnde
IN8BIO, INC. Investor Relations Kontakt -
PROKIDNEY CORP. Investor Relations Kontakt -
X4 PHARMACEUTICALS, INC. Investor Relations Kontakt -
AURINIA PHARMACEUTICALS INC. Investor Relations Kontakt 15.07.2022
ACHILLION PHARMACEUTICALS, INC. Public Communications Contact -
Sehen Sie sich die Erfahrung von Glenn Schulman im Detail an

Ausbildung von Glenn Schulman

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Unternehmensverbindungen

Private Unternehmen9

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Glenn Schulman